Literature DB >> 25265110

Emergency surgery for colorectal cancer does not result in nodal understaging compared with elective surgery.

Sunil V Patel1, Sanjay V B Patel1, Muriel Brackstone2.   

Abstract

BACKGROUND: It has been suggested that inadequate lymph node harvest may result in pathologically understaged or indeterminate staging of patients with colorectal cancer (CRC). We compared the adequacy of nodal staging in patients undergoing emergency surgery compared with elective surgery for CRC.
METHODS: Using a prospectively collected CRC surgery database at a tertiary care centre, we performed a cohort study. The mean number of lymph nodes harvested and the proportion of patients who had inadequate staging (< 12 nodes harvested) were compared between emergency and elective surgery cohorts. Our analysis was adjusted for tumour site, type of resection, surgical training and pathologic stage.
RESULTS: A total of 1279 of 1356 (94%) enrolled patients had nodal data available for analysis; 161 (13%) patients had emergency surgery and 1118 (87%) had elective surgery. The mean number of nodes removed was higher in the emergency surgery group (mean difference +2.8, 95% confidence interval [CI] 0.6-5.1, p = 0.012). The proportion of patients with inadequate nodal staging did not differ between groups (emergent 16%, elective 17%, p = 0.79). The odds of adequate nodal staging, adjusting for site, type of resection, training and stage was no different between groups (OR 0.80, 95% CI 0.47-1.35, p = 0.41).
CONCLUSION: The evidence does not support the common belief that emergency surgery is more commonly understaged in CRC. Our data suggest emergency surgery resulted in a significant increase in the average number of nodes harvested, with no difference in inadequate nodal staging.

Entities:  

Mesh:

Year:  2014        PMID: 25265110      PMCID: PMC4183683          DOI: 10.1503/cjs.019313

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  17 in total

1.  The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.

Authors:  Richard S Swanson; Carolyn C Compton; Andrew K Stewart; Kirby I Bland
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

Review 2.  NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

Authors: 
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

3.  Lymph node harvest in emergent versus elective colon resections.

Authors:  Aaron Lewis; Gabriel Akopian; Sharon Carillo; Howard S Kaufman
Journal:  Am Surg       Date:  2012-10       Impact factor: 0.688

Review 4.  Adjuvant therapy of colon cancer.

Authors:  J S Macdonald
Journal:  CA Cancer J Clin       Date:  1999 Jul-Aug       Impact factor: 508.702

5.  Lymph node evaluation in colorectal cancer patients: a population-based study.

Authors:  Nancy N Baxter; Dan J Virnig; David A Rothenberger; Arden M Morris; Jose Jessurun; Beth A Virnig
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

6.  Obstructing carcinomas of the colon.

Authors:  J W Serpell; F T McDermott; H Katrivessis; E S Hughes
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

7.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

8.  The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.

Authors:  M D Evans; K Barton; A Rees; J D Stamatakis; S S Karandikar
Journal:  Colorectal Dis       Date:  2007-03-07       Impact factor: 3.788

Review 9.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Authors:  Sharlene Gill; Charles L Loprinzi; Daniel J Sargent; Stephan D Thomé; Steven R Alberts; Daniel G Haller; Jacqueline Benedetti; Guido Francini; Lois E Shepherd; Jean Francois Seitz; Roberto Labianca; Wei Chen; Stephen S Cha; Michael P Heldebrant; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2004-04-05       Impact factor: 44.544

View more
  3 in total

1.  Emergency surgery for colorectal cancer does not affect nodal harvest comparing elective procedures: a propensity score-matched analysis.

Authors:  Gianluca Costa; Laura Lorenzon; Giulia Massa; Barbara Frezza; Mario Ferri; Pietro Fransvea; Paolo Mercantini; Maria Cristina Giustiniani; Genoveffa Balducci
Journal:  Int J Colorectal Dis       Date:  2017-07-28       Impact factor: 2.571

2.  Long-term oncological outcomes following emergency resection of colon cancer.

Authors:  Kerollos Nashat Wanis; Michael Ott; Julie Ann M Van Koughnett; Patrick Colquhoun; Muriel Brackstone
Journal:  Int J Colorectal Dis       Date:  2018-06-26       Impact factor: 2.571

3.  Clinico-pathological Features of Colon Cancer Patients Undergoing Emergency Surgery: A Comparison Between Elderly and Non-elderly Patients.

Authors:  Gianluca Costa; Barbara Frezza; Pietro Fransvea; Giulia Massa; Mario Ferri; Paolo Mercantini; Genoveffa Balducci; Antonio Buondonno; Aldo Rocca; Graziano Ceccarelli
Journal:  Open Med (Wars)       Date:  2019-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.